Morning Overview on MSN
RNA-guided CRISPR tool turns genes on with dose control
Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...
The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results